title: Rash from newer cancer agents: why do we still not have effective therapy for palliation and/or prevention?
authors.affiliation: Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Matthew
authors.initials: M
authors.lastname: Butts
authors.forename: Aminah
authors.initials: A
authors.lastname: Jatoi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005076:Exanthema / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D010166:Palliative Care
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors
references.citation: Clin Cancer Res. 2007 Jul 1;13(13):3913-21
references.pmid: 17606725
references.citation: J Clin Oncol. 2010 Mar 10;28(8):1351-7
references.pmid: 20142600